Format
Items per page
Sort by

Send to:

Choose Destination

Links from Protein

Items: 1 to 20 of 276

2.

Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay

Source:
ChEMBL
Protein Target:
Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD_antigen=CD340
3.

Binding affinity to EGFR T790M/L858R double mutant (unknown origin)

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
4.

Competitive binding affinity to human ERBB2 in presence of immobilized ligand

Source:
ChEMBL
Protein Target:
Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD_antigen=CD340
5.

Competitive binding affinity to human EGFR T790M mutant in presence of immobilized ligand

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
AID:
1255234
6.

Inhibition of ERBB2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay

Source:
ChEMBL
Protein Target:
Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD_antigen=CD340
7.

Inhibition of ERBB2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control

Source:
ChEMBL
Protein Target:
Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD_antigen=CD340
8.

Inhibition of EGFR L858R mutant (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
9.

Inhibition of ErbB2 (unknown origin) at 1 uM by FRET method

Source:
ChEMBL
Protein Target:
Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD_antigen=CD340
10.

Inhibition of human EGFR T790M/L858R mutant at 0.01 uM

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
11.

Inhibition of human EGFR T790M mutant at 0.01 uM

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
12.

Inhibition of human EGFR T790M/L858R mutant at 0.1 uM

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
13.

Inhibition of human EGFR T790M mutant at 0.1 uM

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
14.

Inhibition of human recombinant ErbB2

Source:
ChEMBL
Protein Target:
Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD_antigen=CD340
15.

Inhibition of EGFR L858R mutant (unknown origin) by HTRF assay in presence of 2 mM of ATP

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
16.

Inhibition of EGFR L858R mutant (unknown origin) by HTRF assay in presence of Km of ATP

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
AID:
1250408
17.

Inhibition of EGFR exon19 deletion mutant (unknown origin) by HTRF assay in presence of 2mM of ATP

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
18.

Inhibition of EGFR exon19 deletion mutant (unknown origin) by HTRF assay in presence of Km of ATP

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
AID:
1250405
19.

Inhibition of EGFR T790M/L858R mutant (unknown origin) at 100 nM

Source:
ChEMBL
Protein Targets:
Epidermal growth factor receptor; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1; ...
Total:
4
20.

Inhibition of recombinant ERBB2 (unknown origin) at 1 uM after 3 hrs

Source:
ChEMBL
Protein Target:
Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; MLN 19; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Tyrosine kinase-type cell surface receptor HER2; p185erbB2; CD_antigen=CD340
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Refine your results

• What's this?

Actions on your results

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center